5-hydroxypropafenone has been researched along with Tachycardia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gries, J; Hofmann, HP; Kreiskott, H; Kretzschmar, R; Müller, CD; Raschack, M; Teschendorf, HJ; von Philipsborn, G | 1 |
| Axelson, JE; Dodo, H; Freedom, R; Giesbrecht, E; Gow, R; Ito, S; Koren, G; Rosenberg, HC; Tonn, GR; Verjee, Z; Zalzstein, E | 1 |
| Danilo, P; Forster, M; Malfatto, G; Rosen, MR; Sodowick, B; Zaza, A | 1 |
3 other study(ies) available for 5-hydroxypropafenone and Tachycardia
| Article | Year |
|---|---|
Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
Topics: Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Calcium Channel Blockers; Dogs; Electrocardiography; Electroencephalography; Electrophysiology; Female; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Myocardial Infarction; Propafenone; Propiophenones; Rabbits; Rats; Rats, Inbred Strains; Tachycardia | 1984 |
Intravenous and oral propafenone for treatment of tachycardia in infants and children: pharmacokinetics and clinical response.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Metabolic Clearance Rate; Propafenone; Tachycardia; Treatment Outcome | 1998 |
Electrophysiologic, inotropic and antiarrhythmic effects of propafenone, 5-hydroxypropafenone and N-depropylpropafenone.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dogs; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Membrane Potentials; Myocardial Contraction; Papillary Muscles; Propafenone; Purkinje Fibers; Tachycardia | 1988 |